NURS FPX6024 Assessment 2 Population Health Policy Proposal
Assessment 2: Population Health Policy Proposal
Month Date, Year
Policy Proposal Regarding Patient Problem/Disease and Proposed Policies and Guidelines
Technology enhances the ability of healthcare professionals to boost ability to improve patient care outcomes. This policy proposal relates to vulnerable population of patients who are above 50 and need the best practices to reduce the healthcare issue such as CVID disease. It is important for nurses to take into consideration the cultural competence to choose the best practices. These best practices discussed in the previous position paper aim to make references to some benchmarks that must be achieved by the organization. The goal of these best practices is to develop guidelines to enhance the care outcomes for the vulnerable CVID pateints (). For instance, the national guidelines provided by the American Association of Oral and Maxillofacial Surgeons (AAOMS) help nurses to understand a variety of different genetic abnormalities in the older pateints. Master’s prepared nurses in the previous report disclosed and analyzed some vital factors to address the weaknesses of our healthcare system in regards to CVID management improvement. In this report, the proposal is presented that allows nurses and decision makers to improve health care outcomes for the target nicotine addict patients. Therefore, this report builds upon the previously prepared report that aims to improve the quality outcomes of Vila Health Hospital (Szczawinska-Poplonyk et al., 2021).
The nurses analyzed the different opposing viewpoints and supporting suggestions to achieve their objectives related to nicotine addiction interventions. For the Patient named Carl, an above 60 old age patient and a single male parent suffering from CVID disease due to several addiction such as tobacco, nurses will help the management to build and advocate for policies which can be both external (state, federal, or local) or can be internal to ensure quality care and compliance (Maglione, 2020). This report aims to improve the current state of outcomes related to CVID management, diagnosis, and treatment and will help to resolve interpersonal conflicts related to understanding this rare old age disease that is uncommon in the Vila Health System.
Since the committee is convinced the position paper provided was able to make arguments which can improve the time and effort of professionals to improve interprofessional approaches, this policy proposal contains evidence-based practices to illustrate why CVID policy proposals are likely to be successful in the context of Vila System. Even though professionals in Vila Health System can be effective providers who can apply strategies to improve CVID treatment and interventions, a few of them effectively follow and build strategies to raise awareness of patients (Kahrizi et al., 2021). In the presence of the knowledge gap and this uncertainty, in healthcare organization, systematic policy changes are required to enhance the effectiveness of proposed policies. The following strategies can help professionals to achieve their targets to help the patient care problem:
- In order to avoid Aberrant T-cell functions predispose to autoimmune, inflammatory and lymph proliferative complications, the professionals should use immunosuppressive anti-inflammatory therapy.
- Proactive counselling is another vital policy proposal that requires counseling to pateints delivered using outbound phone or Skype calls with patients and their families. This will spread awareness regarding hazards of CVID disease and tell patients more about their life expectancy and the kind of treatment they can expect to receive. This strategy can be used as standalone procedure or can also be used in combination of medications.
- The hospital can use short text messaging service to independently teach the population about CVID disease and its interventions by using a unique UAN number.
- The organization can use web or online techniques to increase the CVID treatment and diagnosis guidance and can also use cognitive behavioral therapy CBT to change patients’ behaviors.
- The practitioners can also combine medications and other proposed treatments with replacement Ig therapy.
- The specialists of this disease can also use a therapy or the intervention known as adjunct antimicrobial prophylaxis.
These best practices can serve as a benchmark to inform the policy guidelines to enhance care outcomes related to CVID disease in older patients above 50. Moreover, technology can be used significantly to understand the genetics of CVID in elderly patients. For example, pathogenesis has helped practitioners to significantly enhance the management of vulnerable patients in their middle and old ages. For example, the study by Franxman, Howe & Baker (2014) helps to extend the use of next generation technology to illustrate the reduction of TCR (T Cells receptors). Technology has also helped to improve the development of mutant protein that impacts B-cells differentiation leading to the decline in the production of vitro plasma blast.
The Need for the Proposed Policy Guidelines and Practices and Opposing Viewpoints
The 2020 Surgeon’s General Report states the importance of discussing and setting the need for CVID intervention guidelines to improve the safety and quality outcomes. Spreading awareness and knowledge empowerment can help nurses and patients to reduce the risk of CVID-related disparities by using intravenous immunoglobulin infusions (Lee et al., 2022). The need for this policy becomes crucial even more to save the elderly patients from falling prey to other mental health issues like COPD, hypertension, and depression. Some specialist doctors believe that using immunoglobulin injection can help the practitioners to solve the problem of elderly patients partially. They believe that it can help to partially restore immunoglobulin levels of the elderly patient (Kahrizi, 2021). The purpose is to provide ample supply of immunoglobulin to the patient named Carl and the practitioners have discussed that both of these ways to provide immunoglobulin can help the patient to receive antibodies from the blood of healthy people who are willing to donate their blood for this good cause.
The National Institute of Allergy and Infectious Diseases also provide guidelines related to the solution of immunoglobulin provision to the patient. Since these patients of CVID are affected significantly with bacterial infections and bacterial issues, antibiotic medications can serve as a new berating ground for their health or terrible old age condition. Moreover, the experts have been consulted for this matter in the NIH.org who suggests changing behaviors of patients though counselling. This will also help nurses to provide their services in a cost-effective manner and reduce the risk of many adverse health issues such as stroke, cardiovascular diseases, or even depression. Therefore, immunoglobulin delivery guidelines play an indispensable role in reducing the risk of heart attack and forming blood cancer cells. It can also help to reduce the risk of COPD disease. Moreover, following these guidelines is extremely important for healthcare professionals because it will also allow them to reduce hospitals’ readmission costs and reduce the financial burdens on people who smoke consistently. There will be far reaching impacts on the healthcare organizations and the whole society if this plan is followed adequately without delay.
The Primary Immunodeficiency Center at Mayo Clinic also that is actively taking a vital part in the research of immunodeficiency disorders that affect elderly patients of CVID. The certified physicians can guide Vila Health Hospital’s staff to deal with primary immunodeficiency disorders and conditions. Our experts can gain new knowledge from useful guidelines to conduct an analysis of DNA when people inherit genes which become a reason for causing CVID disease. Therefore, effective cessation polices and coverage is necessary in today’s context to minimize the hurdles and complexities to accessing cessation treatments such as coinsurance, deductibles, annual or lifetime dollar limits (Farmer et al., 2018)
One observation in Vila Health Organization suggests that immunodeficiency disorders’ treatments will have a potentially short or medium-term impact on CVID patients at the moment because obtaining long term impacts are difficult and need significant time and effort investment to research for the information regarding treating genetically dangerous disorders. Moreover, some doctors in Vila System argue that there is no need to find appropriate donors because the cells of the patient Carl are enough to deal with this situation.
The Potential of the Interprofessional Approach to Implement the Proposed Policy to Increase Effectiveness
Finally, there is a need to comprehend benefits and risks associated with not continuously evaluating of treating immunodeficiency disorders which cause CVID inpatients. Doctors also agree on the fact that such frameworks and guidelines and policies are not yet been covered in detail in the recent years. Our research and new improved policy can help the community to reduce ambiguity and will allow services to be more effective to use policies for the betterment of the society. The evidence shows that our organization can help professionals and nurses to reduce the risk of readmissions. According to the study of Szczawinska-Poplonyk (2021), nowadays, this era is the most important and ideal time to implement CVID interventions policies in medical centers. The brief implementation approaches can be more beneficial due to being less resource-intensive. This helps clinicians to improve their overall behavior and focus on new frameworks and suggestions of care to ensure long-term success.
Even though the implementation of new models of care and change of practices and policies in Vila Hospital is challenging for many professionals, there is a dire need for improving ongoing improvement strategies to gain sustainable success and advantage over rivals (Lim & Ha, 2019). This is vital because the immunodeficiency disorders like CVID and its treatment is expensive and rare in many hospitals when it comes to effectiveness of outcomes. The above-mentioned programs and policies should accompany professionals with a solidly articulated evaluation goal and plan that helps to define implementation outcomes effectively (Chan et al., 2022). Furthermore, with the help of these implementation outcomes, masters prepared nurses can also advocate for improvements in the reporting of interventions and can enhance the proficiency of publications that help patients and the whole society to follow and implement these CVID prevention guidelines and interventions. Therefore, planning is recommended in the short time frame. The use of resourcing will help to invest viably in multi-strategic approach while it will drive successful implementation of policies. Gene therapy involves stem cells correction through intravenous infusion.
Chan, S., Godsell, J., Horton, M., Farchione, A., Howson, L. J., Margetts, M., … & Bryant, V. L. (2022). Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency. Frontiers in immunology, 13, 815193-815193.
Farmer, J. R., Ong, M. S., Barmettler, S., Yonker, L. M., Fuleihan, R., Sullivan, K. E., … & Walter, J. E. (2018). Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets. Frontiers in immunology, 8, 1740.
Franxman, T. J., Howe, L. E., & Baker, J. R. (2014). Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. Journal of clinical immunology, 34(7), 820-827.
Kahrizi, S., Afrooz, G., Hassanzadeh, S., Sherkat, R., & Ghasemi, R. (2021). Developing a Logo Therapy Focused Program for Individual with Common Variable Immunodeficiency Disease (CVID): Efficacy on Resilience and Quality of Life. Razi Journal of Medical Sciences, 28(6), 0-0.
Lee, E. Y., Betschel, S., & Grunebaum, E. (2022). Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review. Allergy, Asthma & Clinical Immunology, 18(1), 1-10.
Maglione, P. J. (2020). Chronic lung disease in primary antibody deficiency: diagnosis and management. Immunology and Allergy Clinics, 40(3), 437-459.
Szczawinska-Poplonyk, A., Schwartzmann, E., Bukowska-Olech, E., Biernat, M., Gattner, S., Korobacz, T., … & Wiczuk-Wiczewska, M. (2021). The pediatric common variable immunodeficiency—from genetics to therapy: a review. European journal of pediatrics, 1-13.